Radiogenomics in Renal Cancer Management—Current Evidence and Future ProspectsMatteo Ferro, Octavian Sabin Tătaru, Gennaro Musi et al.|International Journal of Molecular Sciences|2023Cited by 124
Neutrophil percentage-to-albumin Ratio Predicts Mortality in Bladder Cancer Patients Treated With Neoadjuvant Chemotherapy Followed By Radical CystectomyMatteo Ferro, Mihai Dorin Vartolomei, Riccardo Autorino et al.|Future Science OA|2021Cited by 79
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium)Alessandro Tafuri, Alessandro Antonelli, Michele Marchioni et al.|World Journal of Urology|2022Cited by 34
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort AnalysisMatteo Ferro, Emanuele Zaffuto, Francesco Del Giudice et al.|Cancers|2021Cited by 33
Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancerWojciech Krajewski, Ekaterina Laukhtina, Júlia Aumatell et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 29